ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53

被引:32
|
作者
Roobol, Anne [2 ,3 ]
Roobol, Jo [2 ,3 ]
Carden, Martin J. [2 ,3 ]
Bastide, Amandine [1 ]
Willis, Anne E. [1 ]
Dunn, Warwick B. [4 ,5 ]
Goodacre, Royston [4 ,5 ]
Smales, C. Mark [2 ,3 ]
机构
[1] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England
[2] Univ Kent, Ctr Mol Proc, Sch Biosci, Canterbury CT2 7NJ, Kent, England
[3] Univ Kent, Prot Sci Grp, Sch Biosci, Canterbury CT2 7NJ, Kent, England
[4] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England
[5] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
ataxia telangiectasia mutated- and Rad3-related kinase (ATR); Chinese-hamster ovary cell (CHO cell); cold shock; hypothermia; lipidomics; metabolomics; p53; COLD-SHOCK RESPONSE; RADIOSENSITIZING AGENT; PHOSPHORYLATION; PROTEIN; INHIBITION; HYPOXIA; ARREST; GROWTH; PRODUCTIVITY; EXPRESSION;
D O I
10.1042/BJ20101303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vitro cultured mammalian cells respond to mild hypothermia (27-33 degrees C) by attenuating cellular processes and slowing and arresting the cell cycle. The slowing of the cell cycle at the upper range (31-33 degrees C) and its complete arrest at the lower range (27-28 degrees C) of mild hypothermia is effected by the activation of p53 and subsequent expression of p21. However, the mechanism by which cold is perceived in mammalian cells with the subsequent activation of p53 has remained undetermined. In the present paper, we report that the exposure of Chinese-hamster ovary-K1 cells to mildly hypothermic conditions activates the ATR (ataxia telangiectasia mutated- and Rad3-related kinase)-p53-p21 signalling pathway and is thus a key pathway involved in p53 activation upon mild hypothermia. In addition, we show that although p38(MAPK) (p38 mitogen-activated protein kinase) is also involved in activation of p53 upon mild hypothermia, this is probably the result of activation of p38(MAPK) by ATR. Furthermore, we show that cold-induced changes in cell membrane lipid composition are correlated with the activation of the ATR-p53-p21 pathway. Therefore we provide the first mechanistic detail of cell sensing and signalling upon mild hypothermia in mammalian cells leading to p53 and p21 activation, which is known to lead to cell cycle arrest.
引用
收藏
页码:499 / 508
页数:10
相关论文
共 50 条
  • [41] Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
    Nicholas R. Jette
    Suraj Radhamani
    Greydon Arthur
    Ruiqiong Ye
    Siddhartha Goutam
    Anthony Bolyos
    Lars F. Petersen
    Pinaki Bose
    D. Gwyn Bebb
    Susan P. Lees-Miller
    British Journal of Cancer, 2020, 122 : 1872 - 1872
  • [42] Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
    Charrier, Jean-Damien
    Durrant, Steven J.
    Golec, Julian M. C.
    Kay, David P.
    Knegtel, Ronald M. A.
    MacCormick, Somhairle
    Mortimore, Michael
    O'Donnell, Michael E.
    Pinder, Joanne L.
    Reaper, Philip M.
    Rutherford, Alistair P.
    Wang, Paul S. H.
    Young, Stephen C.
    Pollard, John R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) : 2320 - 2330
  • [43] Discovery of potent and selective inhibitors of Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents
    Charrier, Jean-Damien
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [44] Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin
    Hahm, Eun-Ryeong
    Lee, Joomin
    Abella, Terric
    Singh, Shivendra V.
    MOLECULAR CARCINOGENESIS, 2019, 58 (11) : 2139 - 2148
  • [45] Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
    Sultana, Rebeka
    Abdel-Fatah, Tarek
    Perry, Christina
    Moseley, Paul
    Albarakti, Nada
    Mohan, Vivek
    Seedhouse, Claire
    Chan, Stephen
    Madhusudan, Srinivasan
    PLOS ONE, 2013, 8 (02):
  • [46] Ovarian and uterine carcinosarcoma cell lines show preclinical sensitivity to BAY 1895344, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor
    Manavella, Diego
    Harold, Justin
    Bellone, Stefania
    Hartwich, Tobias
    Mutlu, Levent
    Tymon-Rosario, Joan
    Siegel, Eric
    Altwerger, Gary
    Menderes, Gulden
    Ratner, Elena
    Huang, Gloria
    Clark, Mitchell
    Andikyan, Vaagn
    Azodi, Masoud
    Schwartz, Peter
    Alexandrov, Ludmil
    Santin, Alessandro
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S9 - S9
  • [47] The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells
    Moolmuang, Benchamart
    Ruchirawat, Mathuros
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (01) : 40 - 51
  • [48] Discovery of Thieno[3,2-d]pyrimidine derivatives as potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) kinase
    Duan, Yunxin
    Cheng, Haodong
    Zhuang, Lili
    Xia, Jiawei
    Xu, Yerong
    Zhang, Ruyue
    Sun, Rui
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 255
  • [49] Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent
    Foote, Kevin M.
    Nissink, J. Willem M.
    McGuire, Thomas
    Turner, Paul
    Guichard, Sylvie
    Yates, James W. T.
    Lau, Alan
    Blades, Kevin
    Heathcote, Dan
    Odedra, Rajesh
    Wilkinson, Gary
    Wilson, Zena
    Wood, Christine M.
    Jewsbury, Philip J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 9889 - 9907
  • [50] Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase
    Fontana, E.
    Lee, E.
    Rosen, E.
    Spigel, D.
    Hojgaard, M.
    Lheureux, S.
    Mettu, N. B.
    Carter, L.
    Plummer, R.
    Manley, P.
    Ulanet, D.
    Rimkunas, V.
    Silverman, I. M.
    O'Connell, J.
    McDougall, R.
    Wainszelbaum, M.
    Xu, Y.
    Koehler, M.
    Fretland, A. J.
    Yap, T. A.
    ANNALS OF ONCOLOGY, 2022, 33 : S3 - S4